Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1512 of 6351
-
Virtual reality could replace pills for Kids' casting pain
Symptom relief Recruiting nowThis prospective randomized controlled trial will evaluate whether virtual reality can reduce procedural distress in children undergoing cast application for forearm fractures. Children will be assigned to either a virtual reality group or a standard care group. In the virtual re…
Sponsor: Başakşehir Çam & Sakura City Hospital • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Can acupuncture and magnetic pulses restore arm function after a stroke?
Disease control Not yet recruitingThis study aims to compare the improvement effects of the rTMS (repetitive transcranial magnetic stimulation) combined with conventional rehabilitation therapy group with the rTMS combined with scalp acupuncture and conventional rehabilitation therapy group. Through statistical a…
Sponsor: Debiao Kong • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New heart ablation method could be safer, trial aims to prove
Disease control Recruiting nowThe goal of this clinical trial is to evaluate whether pulsed field ablation (PFA) using the novel VOLT catheter is as safe and effective as conventional thermal ablation (radiofrequency or cryotherapy) for the treatment of atrial fibrillation (AF) in adult patients undergoing th…
Sponsor: Sebastien Knecht • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New combo pill aims to protect kidneys in High-Risk patients
Disease control OngoingInternational, Multicenter and Double-Blind study. The purpose is to measure the effect of baxdrostat in combination with dapagliflozin compared with baxdrostat/placebo on albuminuria, as well as safety, in participants with chronic kidney disease and high blood pressure.
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New COVID booster vaccine tested as nasal spray and shot
Vaccine OngoingThis phase 1 clinical trial will evaluate the safety, reactogenicity, and immunogenicity of Boost-2867, given intramuscular (IM) with or without adjuvant or intranasal (IN) without adjuvant, as a booster dose to previously vaccinated healthy adults. Each of the study sites will b…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 14:02 UTC
-
Could a pill and gel combo restore skin color in vitiligo?
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, and safety of SHR0302 tablets as single therapy or in combination with SHR0302 Base gel for patients with non-segmental vitiligo.
Phase 2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for PNH patients: LP-005 shows promise in long-term trial
Disease control Not yet recruitingThis is an extension study for patients who have completed a prior P10-LP005-02 clinical study. The aim of this study is to evaluate the long-term safety, efficacy, and pharmacokinetics of LP-005 injection in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
Phase 2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Collagen wrap may help hands heal better after tendon surgery
Disease control CompletedTendon injuries of the hand, particularly extensor tendons, are prone to postoperative adhesions, extensor lag, and stiffness, leading to functional impairment. This multicentric randomized controlled trial evaluates whether wrapping repaired extensor tendons with a high-purity T…
Sponsor: Adichunchanagiri Institute of Medical Sciences, B G Nagara • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New eye drop takes on pesky eyelash mites
Disease control Recruiting nowThis is a randomized, double-masked, placebo-controlled, dose-ranging, parallel-group, multi-center study designed to evaluate the safety and efficacy of GLK-321 in patients with Demodex blepharitis.
Phase 2 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for tough arthritis cases: experimental drug enters Mid-Stage trial
Disease control Recruiting nowThis study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to severe rheumatoid arthritis (RA) who have an inadequate response or intolerance to TNF and/or JAK inhibitors.
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New drug offers hope for breast cancer patients suffering from hot flashes
Symptom relief Recruiting nowThis is a phase II, randomized, double-blinded, placebo-controlled trial designed to evaluate the efficacy of fezolinetant (45 mg a day) vs. placebo in reducing moderate to severe vasomotor symptoms (VMS) in breast cancer survivors on endocrine therapy (tamoxifen, aromatase inhib…
Phase 2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
AI spots silent liver danger in ER scans
Diagnosis By invitation onlyHepatic steatosis is a common radiographic "incidental finding" that is overlooked and underreported to patients. The investigators developed a clinical decision support system using machine learning and natural language processing that will prompt reporting to patients and provi…
Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Ultrasound study to see if guselkumab eases psoriatic arthritis
Disease control Recruiting nowThe purpose of this study is to assess how well guselkumab works in improving symptoms of psoriatic arthritis (an inflammatory disease that affects the joints in participants with psoriasis, a skin condition that causes red, scaly patches) using muscoloskeletal ultrasound (MSUS) …
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New RSV vaccine study aims to protect vulnerable patients
Vaccine Recruiting nowThis clinical trial is being done to learn more about how well a vaccine (Arexvy®) for respiratory syncytial virus, also known as RSV, works in people with weakened immune systems. The main questions it aims to answer are: * Does 1 or 2 doses of Arexvy work better in people with…
Phase 2 • Sponsor: Johns Hopkins University • Aim: Vaccine
Last updated Jun 27, 2026 08:03 UTC
-
Immune booster drug tested on rare cancers
Disease control Recruiting nowThe purpose of the study is to find out if pembrolizumab is a useful treatment that causes few or mild side effects in people with ultra-rare sarcoma. The researchers will also study how the immune system responds to the study treatment. Pembrolizumab is a type of drug called a …
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
AI takes on ear infections: could cut unnecessary antibiotics in kids
Diagnosis Recruiting nowEar infections are common in young children with cold symptoms, but they can be difficult to diagnose due to small ear canals, child movement, and limited viewing time. In this study, investigators will take photos of the eardrums of children 6-24 months of age with upper respira…
Sponsor: Timothy Shope • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Could a sleep pill curb alcohol cravings? new trial investigates
Disease control Recruiting nowThe goal of this clinical trial is to learn if, how, and for whom suvorexant (SUV) works to treat alcohol use disorder (AUD). The main questions it aims to answer are: * Is SUV effective for AUD? * Does SUV dampen stress reactivity? * Can the researchers develop a biomarker for …
Phase 2 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Gene therapy targets chronic nerve pain in new trial
Disease control Recruiting nowThis research is being done to study a possible treatment for refractory pain due to small fiber neuropathy (SFN). ST-503 is intended to deliver a modified copy of the gene which will ideally repress Nav1.7 tissue-related pain signals reaching the brain, which should reduce the …
Phase 1/2 • Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a cancer drug combo fight frailty in HIV?
Disease control OngoingThis clinical trial is a Phase II study designed to test the safety and effectiveness of a combination of dasatinib and quercetin (D+Q) in improving physical function for people with HIV who are frail or prefrail. The study will involve 80 participants, all aged 50 or older, who …
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New MRI scan could spare kidney transplant patients painful biopsies
Diagnosis Recruiting nowThis clinical study aims to investigate a new, non-invasive method for monitoring kidney function after transplantation. Currently, assessing the health of a transplanted kidney often relies on blood tests or invasive biopsies, which may not detect subtle early changes or account…
Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC